New bird flu vaccine development gathers pace amid fears of pandemic
To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu vaccine development. The vaccine aims to combat current bird flu strains in wild birds, poultry, and dairy cows, leveraging quicker production and easier updates compared to traditional vaccines.
To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu vaccine development. The vaccine aims to combat current bird flu strains in wild birds, poultry, and dairy cows, leveraging quicker production and easier updates compared to traditional vaccines.
